WallStreetZenWallStreetZen

NASDAQ: NKTX
Nkarta Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for NKTX

Based on 2 analysts offering 12 month price targets for Nkarta Inc

Min Forecast
$10.00+350.45%
Avg Forecast
$10.50+372.97%
Max Forecast
$11.00+395.5%

Should I buy or sell NKTX stock?

Based on 2 analysts offering ratings for Nkarta Inc.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although NKTX's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates NKTX as a "Hold". Stocks with a Zen Rating of Hold have had an average return of +7.53% per year. Learn More

Be the first to know when Wall Street analysts revise their NKTX stock forecasts and price targets.

NKTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-11
lockedlocked$00.00+00.00%2025-08-13

1 of 1

Forecast return on equity

Is NKTX forecast to generate an efficient return?

Company
-26.16%
Industry
337.03%
Market
215.3%
NKTX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NKTX forecast to generate an efficient return on assets?

Company
-20.69%
Industry
118.5%
NKTX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NKTX earnings per share forecast

What is NKTX's earnings per share in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
-$1.37
Avg 2 year Forecast
-$0.96
Avg 3 year Forecast
-$1.58

NKTX revenue forecast

What is NKTX's revenue in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$0.0
Avg 2 year Forecast
$0.0
Avg 3 year Forecast
$2.7M

NKTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NKTX$2.22$10.50+372.97%Strong Buy
ABOS$2.57$7.50+191.83%Strong Buy
IPHA$1.78$5.00+180.90%Buy
IPSC$1.84$3.00+63.04%Buy
VTVT$41.19$55.25+34.13%Strong Buy
View Top Biotech Stocks

Nkarta Stock Forecast FAQ

Is Nkarta Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: NKTX) stock is to Strong Buy NKTX stock.

Out of 2 analysts, 1 (50%) are recommending NKTX as a Strong Buy, 1 (50%) are recommending NKTX as a Buy, 0 (0%) are recommending NKTX as a Hold, 0 (0%) are recommending NKTX as a Sell, and 0 (0%) are recommending NKTX as a Strong Sell.

If you're new to stock investing, here's how to buy Nkarta stock.

What is NKTX's earnings growth forecast for 2026-2028?

(NASDAQ: NKTX) Nkarta's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 69.56%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.96%.

Nkarta's earnings in 2026 is -$102,610,000.On average, 9 Wall Street analysts forecast NKTX's earnings for 2026 to be -$97,445,388, with the lowest NKTX earnings forecast at -$114,854,721, and the highest NKTX earnings forecast at -$79,801,657. On average, 7 Wall Street analysts forecast NKTX's earnings for 2027 to be -$68,287,773, with the lowest NKTX earnings forecast at -$128,080,416, and the highest NKTX earnings forecast at $89,497,185.

In 2028, NKTX is forecast to generate -$112,297,658 in earnings, with the lowest earnings forecast at -$107,893,829 and the highest earnings forecast at -$115,600,531.

What is NKTX's revenue growth forecast for 2026-2028?

(NASDAQ: NKTX) Nkarta's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 118.38%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.25%.

Nkarta's revenue in 2026 is $0.On average, 8 Wall Street analysts forecast NKTX's revenue for 2026 to be $0, with the lowest NKTX revenue forecast at $0, and the highest NKTX revenue forecast at $0. On average, 6 Wall Street analysts forecast NKTX's revenue for 2027 to be $0, with the lowest NKTX revenue forecast at $0, and the highest NKTX revenue forecast at $0.

In 2028, NKTX is forecast to generate $193,200,273 in revenue, with the lowest revenue forecast at $0 and the highest revenue forecast at $596,647,901.

What is NKTX's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: NKTX) forecast ROA is -20.69%, which is lower than the forecast US Biotechnology industry average of 118.5%.

What is NKTX's Price Target?

According to 2 Wall Street analysts that have issued a 1 year NKTX price target, the average NKTX price target is $10.50, with the highest NKTX stock price forecast at $11.00 and the lowest NKTX stock price forecast at $10.00.

On average, Wall Street analysts predict that Nkarta's share price could reach $10.50 by Nov 11, 2026. The average Nkarta stock price prediction forecasts a potential upside of 372.97% from the current NKTX share price of $2.22.

What is NKTX's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: NKTX) Nkarta's current Earnings Per Share (EPS) is -$1.37. On average, analysts forecast that NKTX's EPS will be -$1.37 for 2026, with the lowest EPS forecast at -$1.62, and the highest EPS forecast at -$1.12. On average, analysts forecast that NKTX's EPS will be -$0.96 for 2027, with the lowest EPS forecast at -$1.80, and the highest EPS forecast at $1.26. In 2028, NKTX's EPS is forecast to hit -$1.58 (min: -$1.52, max: -$1.63).

What is NKTX's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: NKTX) forecast ROE is -26.16%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.